Fadli Robby Amsriza1, Rizka Fakhriani2, Asmaya Aji Pangki3

1Department of Surgery, Muhammadiyah University of Yogyakarta Faculty of Medicine and Health Sciences, Bantul, Indonesia
2Division of Head and Neck Surgery, Department of Otorhinolaryngology, Muhammadiyah University of Yogyakarta Faculty of Medicine and Health Sciences, Bantul, Indonesia
3Department of Surgery, Islam University of Indonesia Faculty of Medicine, Sleman, Indonesia


Objective: Hemorrhoidal disease, which affects nearly 40% of people, is characterized by pathological alterations and distal displacement of hemorrhoidal tissue. The short health scale (SHSHD) and the hemorrhoidal disease symptom score (HDSS) are two tools that can be utilized to assess the quality of life of hemorrhoidal patients. The present study aims to translate, modify, and validate the HDSS and SHSHD questionnaires in Indonesian.

Material and Methods: This cross-sectional study assessed the validity and reliability of the HDSS and SHSHD Indonesian adaptation instrument in hemorrhoidal patients from April 15, 2022, and April 1, 2023.

Results: There were 91 study subjects, 55 males and 36 females. The study showed that the subscale interpretations of the R-values and the full scale scored above 0.25, indicating weak to very strong correlations. These results mean that the HDSS and SHSHD questionnaires are valid for use. Based on the study’s results, the R-value of each item, domain, and total score ≥0.8 (p< 0.05) indicates that the HDSS and SHSHD instruments are reliable.

Conclusion: The Indonesian adaptation of the HDSS and SHSHD demonstrates validity and reliability as an assessment tool for measuring the healthrelated quality of life in Indonesian patients diagnosed with hemorrhoidal disease.

Keywords: Disease, hemorrhoid, quality of life, questionnaires

Cite this article as: Amsriza FR, Fakhriani R, Pangki AA. Translation and validation of Indonesian hemorrhoidal disease symptom score (HDSS) and short health scale hemorrhoidal disease (SHSHD). Turk J Surg 2023; 39 (4): 336-343.


Ethics Committee Approval

This study was approved by Muhammadiyah University of Yogyakarta Faculty of Medicine Health Research Ethics Committee (Decision no: 130/EC-KEPK FKIK UMY/V/2022, Date: 17.05.2022).

Peer Review

Externally peer-reviewed.

Author Contributions

Concept - FRA, RF; Design - FRA, RF; Supervision - FRA; Materials - FRA; Data Collection and/or Processing - FRA, RF; Analysis and/or Interpretation - FRA; Literature Search - RF; Writing Manuscript - FRA, RF; Critical Reviews -FRA, RF.

Conflict of Interest

The authors have no conflicts of interest to declare.

Financial Disclosure

The authors declared that this study has received no financial support.


The study was published with the written consent of the patient.